T Rowe PR Health Science-InvPRHSX
13F holders, Q3 2024 (September 30)5holders −1
0new positions
1sold out
$99.65avg. 13F price*
At the end of Q3 2024, 5 institutions reported holding T Rowe PR Health Science-Inv (PRHSX) in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holders were Ethos Financial Group, LLC ($260K), Westside Investment Management, Inc. ($144K) and Coston, McIsaac & Partners ($85K).
- Company
- T Rowe PR Health Science-Inv
- CUSIP
- 741480107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $34K |
All 13F filers, Q2 2024 → Q3 2024: 405 shares sold, net −405 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Ethos Financial Group, LLC | 0.04% | Reduce -1.6% | 2,591 | $260K |
| Westside Investment Management, Inc. | 0.03% | No change | 1,467 | $144K |
| Coston, McIsaac & Partners | 0.02% | No change | 849 | $85K |
| Financial Gravity Companies, Inc. | 0.00% | — | 99 | $10K |
| Tucker Asset Management LLC | 0.00% | No change | 27 | $3K |
"% of holder's portfolio" is PRHSX's weight in each manager's 13F, not the share of T Rowe PR Health Science-Inv the manager owns.